Study fatty acids and eye disease risk in newborns
Part of Eyes & vision, Women’s health & pregnancy clinical trials.
This study looks at whether fatty acids from the mother are linked to the risk of retinopathy of prematurity, an eye condition that can affect very premature babies. It involves checking factors related to how the body responds to fatty acids during pregnancy and comparing mothers in different pregnancy situations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are the baby’s mother and you are at least 18 years old
- You gave birth either very early (<29 weeks) or at full term (39 to 41 weeks plus 6 days)
- Your participation is voluntary (you allow the researchers to contact/study you)
- You are not in a legal protected situation (you can consent normally)
- You are not currently critically ill
- You (and if term) did not have certain pregnancy health problems or infections in this past pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at newborn eye exams and genetic information to better understand why some premature infants develop a serious vision problem called ROP. You may be invited because your baby needs routine eye screening or is being moved for specialized eye care.
This study looks at whether giving polyunsaturated fatty acids (healthy fats) to preterm babies can help their development. If your baby was born between 24 and 36 weeks and admitted within a day of birth, they may be able to join.
This study looks at eye structure in children who were in an earlier premature-baby eye study and are now around 4.5–5 years old. It may help researchers better understand how eye disease in prematurity develops and how to monitor it.
This study looks at two substances in the blood from the umbilical cord (IL-6 and lactate) to see if they can help doctors understand how well a newborn is doing after birth.
This trial is looking for women with preeclampsia to help find markers in the blood that show how blood vessels are affected. The goal is to better understand the condition and possibly improve future care.
This study looks for biological markers in the mother's blood that might predict how exposure to inflammation during pregnancy could change a baby's brain development. The goal is to understand these effects in healthy pregnancies and those with certain inflammatory conditions.
Hear when a new Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.